Skip to main content
. 2014 Dec 22;2014:120317. doi: 10.1155/2014/120317

Table 2.

Characteristics of hemodialysis patients (n = 893).

Parameter Type 2 DM nephropathy Other causes of ESRD P value
Demographic data n = 366 n = 527

Male sex, n (% of all) 201 (54.9) 307 (58.3) 0.337b
Age at RRT beginning, years 62.9 ± 14.1 57.2 ± 17.2 <0.0001c
RRT duration, years 3.29 (0.06–28.0) 4.42 (0.12–28.2) <0.0001c
Death rate, cases per 100 patient-years 0.48 0.42
Death rate, cases per 100 RRT-years 7.97 4.63

Clinical data n = 332 n = 527

Coronary artery disease, n (% of all) 174 (52.4) 168 (31.9) <0.0001b
Myocardial infarction, n (% of all) 98 (29.5) 101 (19.2) 0.009b
Parathyroidectomy, n (% of all) 2 (0.60) 21 (3.98) 0.0009b
Treatment with cinacalcet hydrochloride 24 (7.2) 98 (18.6) <0.0001b

Laboratory data n = 366 n = 527

Anti-HBc positive, n (% of all) 95 (26.0) 126 (23.9) 0.528b
HBsAg positive, n (% of all anti-HBc positive) 7 (7.4) 11 (8.7) 0.807b
Anti-HCV positive, n (% of all) 26 (7.1) 57 (10.8) 0.062b
HCV RNA positive, n (% of all anti-HCV positive) 14 (53.8) 39 (68.4) 0.225b
Responders to hepatitis B vaccine, n (% of all) 202 (55.2) 315 (59.8) 0.191b
25(OH)D (ng/mL)a 13.3 ± 3.9 14.5 ± 5.6 0.182a,d
Total calcium (mg/dL) 8.83 ± 0.67 8.91 ± 0.82 0.264d
Phosphates (mg/dL) 5.03 ± 1.44 5.25 ± 1.49 0.054d
PTH (pg/mL) 296 (12.9–3,757) 463 (12.7–3,741) <0.0001c
Total alkaline phosphatase (U/L) 98.2 (25.8–1,353) 97.1 (40.5–1,684) 0.528c

25(OH)D: 25-hydroxycholecalciferol, anti-HBc: antibodies to core antigen of hepatitis B virus, anti-HCV: antibodies to hepatitis C virus, HBsAg: surface antigen of hepatitis B virus, DM: diabetes mellitus, ESRD: end-stage renal disease, HCV RNA: ribonucleic acid of hepatitis C virus, PTH: parathyroid hormone, and RRT: renal replacement therapy.

A significant difference is indicated using bold font.

a n = 66 for type 2 DM nephropathy; n = 96 for other renal diseases.

bFisher's exact test.

cMann-Whitney test.

dUnpaired t-test, Welch corrected.